Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2026
Analytical and clinical validation of the Lumipulse G plasma p-tau217 assay for clinical implementationBurak Arslan, Johan Gobom, Ulf Andreasson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2014
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's diseaseHlin Kvartsberg, Flora H Duits, Martin Ingelsson, et al.
Scientific Reports|July 8, 2016
Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiationPetra Bergström, Lotta Agholme, Faisal Hayat Nazir, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 15, 2024
Association of region-specific hippocampal reduction of neurogranin with inflammasome proteins in <i>post mortem</i> brains of Alzheimer's diseaseRegina T Vontell, Ryan Gober, Julian Dallmeier, et al.
Acta Neuropathologica|June 24, 2026
Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDPPrzemysław R Kac, Katheryn A Q Cousins, Alicja Szadziewska, et al.
Brain : a Journal of Neurology|December 14, 2019
Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathologyKaj Blennow, Chun Chen, Claudia Cicognola, et al.
Molecular Psychiatry|October 27, 2020
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging InitiativeThomas K Karikari, Andréa L Benedet, Nicholas J Ashton, et al.
Acta Neuropathologica|April 28, 2018
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathologyErik Portelius, Bob Olsson, Kina Höglund, et al.
Pageof 6